Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizumab

Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizumab

Aim: This ambispective observational study assessed the impact of Noona, an electronic patient-reported outcomes (ePRO) platform, for patients with non-small cell lung cancer (NSCLC) treated in a community oncology setting. Methods: Adults with advanced NSCLC, ECOG performance status of 0–2, who r...

Full description

Saved in:
Bibliographic Details
Main Authors: L. Johnetta Blakely, Sabine Oskar, Ian Kudel, Ashley Roush, Zoya Shamsi, Toni Perry, Annette Christianson, Brittni Smith, Thomas Burke
Format: Article
Language:English
Published: Becaris Publishing Limited 2025-01-01
Series:Journal of Comparative Effectiveness Research
Subjects:
electronic patient-reported outcomes
healthcare resource use
non-small-cell lung cancer
noona
observational study
real-world time on treatment
real-world time to next treatment or death
standard of care
symptoms
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items